IT1260444B - Derivati della 8-(1-amminocicloalchil)1,3-dialchilxantina, procedimenbto di preparazione e loro composizioni farmaceutiche antidepressive, nootropiche e psicostimolanti - Google Patents

Derivati della 8-(1-amminocicloalchil)1,3-dialchilxantina, procedimenbto di preparazione e loro composizioni farmaceutiche antidepressive, nootropiche e psicostimolanti

Info

Publication number
IT1260444B
IT1260444B ITMI920132A ITMI920132A IT1260444B IT 1260444 B IT1260444 B IT 1260444B IT MI920132 A ITMI920132 A IT MI920132A IT MI920132 A ITMI920132 A IT MI920132A IT 1260444 B IT1260444 B IT 1260444B
Authority
IT
Italy
Prior art keywords
aminocycloalkyl
nootropics
psychostimulants
antidepressants
pharmaceutical compositions
Prior art date
Application number
ITMI920132A
Other languages
English (en)
Inventor
Mario Brufani
Original Assignee
Mario Brufani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mario Brufani filed Critical Mario Brufani
Publication of ITMI920132A0 publication Critical patent/ITMI920132A0/it
Priority to ITMI920132A priority Critical patent/IT1260444B/it
Priority to DE69322177T priority patent/DE69322177T2/de
Priority to DK93100723T priority patent/DK0552712T3/da
Priority to EP93100723A priority patent/EP0552712B1/en
Priority to ES93100723T priority patent/ES2125911T3/es
Priority to AT93100723T priority patent/ATE173732T1/de
Priority to US08007757 priority patent/US5378844B1/en
Priority to CN93102055A priority patent/CN1035877C/zh
Priority to CA002087922A priority patent/CA2087922C/en
Publication of ITMI920132A1 publication Critical patent/ITMI920132A1/it
Application granted granted Critical
Publication of IT1260444B publication Critical patent/IT1260444B/it
Priority to GR990400573T priority patent/GR3029476T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Si descrivono dei derivati 8-(1-amminocicloalchil)-1,3-dialchilxantinici ed i loro sali ad attività di antagonisti dell'adenosina. Si descrive inoltre un procedimento per la preparazione di detti composti e loro composizioni farmaceutiche che li contengono come antidepressivi, nootropi e psicostimolanti in terapia.
ITMI920132A 1992-01-24 1992-01-24 Derivati della 8-(1-amminocicloalchil)1,3-dialchilxantina, procedimenbto di preparazione e loro composizioni farmaceutiche antidepressive, nootropiche e psicostimolanti IT1260444B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITMI920132A IT1260444B (it) 1992-01-24 1992-01-24 Derivati della 8-(1-amminocicloalchil)1,3-dialchilxantina, procedimenbto di preparazione e loro composizioni farmaceutiche antidepressive, nootropiche e psicostimolanti
ES93100723T ES2125911T3 (es) 1992-01-24 1993-01-19 Derivados de 8-(1-aminocicloalquil)-1,3-dialquilxantina como antagonistas de receptores de adenosina.
DK93100723T DK0552712T3 (da) 1992-01-24 1993-01-19 8-(1-aminocycloalkyl)1,3-dialkylxanthinderivater som antagonister for adenosinreceptorer
EP93100723A EP0552712B1 (en) 1992-01-24 1993-01-19 8-(1-Aminocycloalkyl)-1,3-dialkylxanthine derivatives as antagonists adenosine receptors
DE69322177T DE69322177T2 (de) 1992-01-24 1993-01-19 8-(1-Aminocycloalkyl)-1,3-Dialkylxanthinderivate als Antagonisten von Adenosinrezeptoren
AT93100723T ATE173732T1 (de) 1992-01-24 1993-01-19 8-(1-aminocycloalkyl)-1,3-dialkylxanthinderivat als antagonisten von adenosinrezeptoren
US08007757 US5378844B1 (en) 1992-01-24 1993-01-22 8-(1-aminocycloalkyl)-1,3-dialkylxanthine derivatives preparation process and antidepressant nootropic and psychostimulant composition thereof
CN93102055A CN1035877C (zh) 1992-01-24 1993-01-22 8-(1-氨基环烷基)-1，3-二烃基黄嘌呤衍生物
CA002087922A CA2087922C (en) 1992-01-24 1993-01-22 8-(1-aminocycloalkyl)-1,3-dialkylxanthine derivatives, preparation process and antidepressant, nootropic and psychostimulant composition thereof
GR990400573T GR3029476T3 (en) 1992-01-24 1999-02-24 8-(1-Aminocycloalkyl)-1,3-dialkylxanthine derivatives as antagonists adenosine receptors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI920132A IT1260444B (it) 1992-01-24 1992-01-24 Derivati della 8-(1-amminocicloalchil)1,3-dialchilxantina, procedimenbto di preparazione e loro composizioni farmaceutiche antidepressive, nootropiche e psicostimolanti

Publications (3)

Publication Number Publication Date
ITMI920132A0 ITMI920132A0 (it) 1992-01-24
ITMI920132A1 ITMI920132A1 (it) 1993-07-25
IT1260444B true IT1260444B (it) 1996-04-09

Family

ID=11361662

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI920132A IT1260444B (it) 1992-01-24 1992-01-24 Derivati della 8-(1-amminocicloalchil)1,3-dialchilxantina, procedimenbto di preparazione e loro composizioni farmaceutiche antidepressive, nootropiche e psicostimolanti

Country Status (10)

Country Link
US (1) US5378844B1 (it)
EP (1) EP0552712B1 (it)
CN (1) CN1035877C (it)
AT (1) ATE173732T1 (it)
CA (1) CA2087922C (it)
DE (1) DE69322177T2 (it)
DK (1) DK0552712T3 (it)
ES (1) ES2125911T3 (it)
GR (1) GR3029476T3 (it)
IT (1) IT1260444B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2928386B2 (ja) * 1992-07-08 1999-08-03 協和醗酵工業株式会社 うつ病治療剤
DE4316576A1 (de) * 1993-05-18 1994-11-24 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 1,3-Dipropyl-8-(3-Oxocyclopentyl)-xanthin
EP0667349B1 (en) * 1993-09-06 2001-01-24 Kyowa Hakko Kogyo Kabushiki Kaisha Depression remedy
US6117870A (en) * 1998-11-12 2000-09-12 Fujirebio Kabushiki Kaisha Cyclic amide derivatives
BR0107532A (pt) * 2000-04-03 2004-11-03 Bristol Myers Squibb Pharma Co Composto, uso do composto, método para o tratamento de disfunções neurológicas associadas com a produção de b-amilóide, método de inibição da atividade de y-secretase e composição farmacêutica
FR2814077A1 (fr) * 2000-09-20 2002-03-22 Inst Nat Sante Rech Med Utilisation de modulateurs de recepteurs a l'adenosine pour reguler la fonction des netrines et/ou de leurs recepteurs
DE602004016328D1 (de) * 2003-05-13 2008-10-16 Hoffmann La Roche 2-imidazo-benzothiazole als adenosin-rezeptor liganden

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879271A (en) * 1953-07-23 1959-03-24 Knoll Ag Basic derivatives of mono- and dimethyl xanthines, and a process of making same
EP0011399A1 (en) * 1978-11-11 1980-05-28 FISONS plc N-substituted theophyllines, processes for their preparation and pharmaceutical compositions containing them
US4772607A (en) * 1986-05-20 1988-09-20 Warner-Lambert Company Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
DE3843117A1 (de) * 1988-12-22 1990-06-28 Boehringer Ingelheim Kg Neue xanthinderivate mit adenosin-antagonistischer wirkung
JP2843634B2 (ja) * 1989-03-06 1999-01-06 協和醗酵工業株式会社 キサンチン誘導体
DE4019892A1 (de) * 1990-06-22 1992-01-02 Boehringer Ingelheim Kg Neue xanthinderivate

Also Published As

Publication number Publication date
US5378844A (en) 1995-01-03
CN1082047A (zh) 1994-02-16
CA2087922A1 (en) 1993-07-25
ITMI920132A1 (it) 1993-07-25
ES2125911T3 (es) 1999-03-16
US5378844B1 (en) 1998-12-01
GR3029476T3 (en) 1999-05-28
CA2087922C (en) 2004-11-30
ATE173732T1 (de) 1998-12-15
DK0552712T3 (da) 1999-08-09
ITMI920132A0 (it) 1992-01-24
EP0552712A1 (en) 1993-07-28
EP0552712B1 (en) 1998-11-25
DE69322177T2 (de) 1999-06-24
CN1035877C (zh) 1997-09-17
DE69322177D1 (de) 1999-01-07

Similar Documents

Publication Publication Date Title
FI902661A0 (fi) Menetelmä angiotensiini-II-antagonisteina aktiivisten 3-(2'-(substituoitu)bifen-4-yyli)metyyli-3H-imidatso/4,5-b/pyridiiniyhdisteiden valmistamiseksi
SE8602723L (sv) Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem
IT8123602A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
ES2164920T3 (es) Nuevos derivados heterociclicos y uso medicinal de los mismos.
FI93350C (fi) Menetelmä uusien farmakologisesti aktiivisten katekolijohdoksien valmistamiseksi
UA34416C2 (uk) Похідні хроману, активні стосовно 5-нт рецептора, спосіб їх одержання та проміжні сполуки
UA19782A (uk) Спосіб одержаhhя біциклічhих складhих ефірів або їх фармацевтичhо прийhятhих солей
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
BR9815296A (pt) Derivados de ácido carboxìlico 3-pirrolidina e ouso dos mesmos como antagonistas endotelina
IT8123603A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
IT8123940A0 (it) Derivati della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che licontengono come principio attivo.
IT1260444B (it) Derivati della 8-(1-amminocicloalchil)1,3-dialchilxantina, procedimenbto di preparazione e loro composizioni farmaceutiche antidepressive, nootropiche e psicostimolanti
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
FI91964C (fi) Menetelmä uusien, farmaseuttisesti aktiivisten 1-(hydroksistyryyli)-5H-2,3-bentsodiatsepiinijohdannaisten valmistamiseksi
NO20000655L (no) 8-substituerte-9H-1,3-Dioxolo/4,5- h//2,3/benzodiazepinderivater, som AMPA/KAINAT reseptorinhibitorer
EA199800701A1 (ru) БЕНЗО[С]ХИНОЛИЗИНОВЫЕ ПРОИЗВОДНЫЕ, ИХ ПОЛУЧЕНИЕ И ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ 5a-РЕДУКТАЗ
ES8801813A1 (es) Procedimiento para preparar 2,4-difenil-1,3-dioxanos
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
ATE79540T1 (de) Pharmazeutische zusammensetzung.
ES8603417A1 (es) Un procedimiento para preparar derivados de dihidropiridina
FI881075A (fi) Menetelmä optisesti aktiivisten, oikealle kiertävien okso-isoindolinyylijohdannaisten valmistamiseksi
DE69000806D1 (de) Indol-derivate.
ES2159098T3 (es) Nuevos derivados de elipticina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2157542T3 (es) Nuevos derivados de elipticina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970117